In this article, we will list the 5 Best Stocks to Invest In According to Two Sigma Advisors with Huge Upside Potential. Please visit 12 Best Stocks to Invest In According to Two Sigma Advisors with Huge Upside Potential if you would like to see the extended list and the methodology behind it.
5. SAP SE (NYSE:SAP)
Stock Upside Potential: 61.39%
Number of Hedge Fund Holders: 34
Two Sigma Advisors’ Stake: $76,263,098
SAP SE (NYSE:SAP) is one of the best stocks to invest in according to Two Sigma Advisors with huge upside potential. On June 10, SAP SE (NYSE:SAP) CTO Philipp Herzig presented at the Bank of America Global Research C-Suite TMT Conference, where he laid out SAP’s AI strategy, product roadmap, and monetization approach.
On AI strategy, Herzig noted that the company’s overarching AI vision, which it calls the Autonomous Enterprise, centers on delivering measurable business outcomes across five core enterprise domains. To deliver on this, SAP plans to release 50 AI-powered assistants by Q3 2026, each orchestrating a set of task-specific agents underneath. He noted that there are currently 200 agents shipping out of the box with SAP’s SaaS applications.
Herzig told the moderator that the newly announced SAP Business AI Platform will underpin the AI strategy. The platform combines the existing SAP Business Technology Platform and SAP Business Data Cloud with a new version of Joule Studio and SAP Signavio to allow companies to first identify where AI can improve their business processes, then build and govern agents to execute on those improvements.
On monetization, Herzig said SAP uses a value-based, consumptive pricing model through a unit he called AI Units. So, customers buy a pool of AI Units that unlocks all premium AI capabilities across the entire SAP portfolio. He added that pricing is pegged to the business value delivered.
SAP SE (NYSE:SAP) is an enterprise software company. It develops and licenses business software for enterprise resource planning, customer relationship management, supply chain management, and human capital management.
4. ExlService Holdings, Inc. (NASDAQ:EXLS)
Stock Upside Potential: 62.30%
Number of Hedge Fund Holders: 38
Two Sigma Advisors’ Stake: $112,958,294
ExlService Holdings, Inc. (NASDAQ:EXLS) is one of the best stocks to invest in according to Two Sigma Advisors with huge upside potential. On June 24, ExlService Holdings, Inc. (NASDAQ:EXLS) announced a definitive agreement to acquire iMerit Inc in a transaction valued at up to $310 million. iMerit is a specialist in AI model training, evaluation, and reinforcement learning.
ExlService said the deal is structured as a cash transaction and that the first part comprises $170 million paid upfront at closing. The payment will be subject to standard debt, cash, and working capital adjustments. The second tranche of $140 million will be in the form of cash incentives and earnouts paid over two years. This one too will be contingent on iMerit hitting specified post-close performance milestones.
The company noted that the transaction will see iMerit bring its Ango platform to ExlService. Ango is a data labeling and annotation tool used in building and refining AI models. The other core asset ExlService will absorb is iMerit’s Scholars expert network. This is a curated community of human domain specialists who support AI model training and evaluation tasks requiring real-world expertise. These capabilities are in high demand among frontier AI labs and large enterprises alike, the company noted.
ExlService plans to integrate both platforms into its existing AI product stack. The goal is to deepen its end-to-end AI offering for regulated industries such as healthcare, insurance, banking, and capital markets.
ExlService Holdings, Inc. (NASDAQ:EXLS) is a business process management and data analytics company. It provides operations management, decision analytics, and digital transformation services to industries including insurance, healthcare, banking, and travel.
3. Wix.com Ltd. (NASDAQ:WIX)
Stock Upside Potential: 64.79%
Number of Hedge Fund Holders: 53
Two Sigma Advisors’ Stake: $163,479,932
Wix.com Ltd. (NASDAQ:WIX) is one of the best stocks to invest in according to Two Sigma Advisors with huge upside potential. On June 18, JPMorgan analyst Alexei Gogolev lowered his price target on Wix.com Ltd. (NASDAQ:WIX) to $62 from $86, and left the Underweight rating on the shares unchanged.
The target cut was part of a broader adjustment JPMorgan made across the internet infrastructure group. In other words, Gogolev’s decision on Wix was not an isolated call but a sector-wide recalibration of price targets to reflect a more challenging operating environment for web services companies.
Independently of the analyst action, on June 15, Wix announced a partnership with Microsoft through which its AI-powered website builder, Wix Harmony, is now accessible directly inside Microsoft 365 Copilot. This means now users do not have to switch between tools to build or manage a web presence.
Wix said the integration is built on top of Copilot’s generally available support for the OpenAI Apps SDK. It also leverages Wix MCP, which allows Microsoft 365 Copilot to interact with Wix’s tools and services through natural language.
The goal is to ensure building professional websites is as simple and intuitive as asking for it in a familiar interface, said Shahar Talmi, GM of Developer Platform at Wix. He added that this move is especially timely as “creation moves into chat-based interfaces.”
Wix.com Ltd. (NASDAQ:WIX) is a cloud-based web development platform company. It provides tools for individuals and businesses to create, manage, and grow their online presence, including website builders, e-commerce solutions, and business management applications.
2. Boston Scientific Corporation (NYSE:BSX)
Stock Upside Potential: 70.19%
Number of Hedge Fund Holders: 106
Two Sigma Advisors’ Stake: $590,554,745
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in according to Two Sigma Advisors with huge upside potential. On June 24, Jefferies analyst Matthew Taylor cut his price target on Boston Scientific Corporation (NYSE:BSX) to $67 from $100, while keeping a Buy rating on the stock.
The analyst stated that a significant downward revision to his firm’s Watchman growth estimates necessitated the target cut. Jefferies reduced its forecast for US Watchman sales growth from 14% for the year to just 5%, citing what it described as significant and accelerating changes in the market for left atrial appendage closure devices.
According to the analyst, a key event that reshaped those expectations was the CHAMPION-AF study. This is a major clinical trial evaluating the Watchman FLX device as a first-line stroke prevention option for patients with atrial fibrillation. Taylor noted that while Boston Scientific officially reported the study met all its primary and secondary endpoints at the American College of Cardiology meeting last April, he described the results as mixed in their real-world market impact. This divergence triggered a reassessment of how aggressively the device would be adopted by physicians.
A day after the Jefferies call, on June 25, Stifel followed suit with a target cut on Boston Scientific to $65 from $75, and left the Buy rating untouched. The firm’s action was informed by insights from five deep left atrial appendage closure physician conversations to discuss why Watchman growth has slowed. One theme that emerged from the conversations was that reactions to multiple recent datasets were negative, which aligns with Jefferies’ position.
Boston Scientific Corporation (NYSE:BSX) is a medical device company. It develops, manufactures, and markets minimally invasive medical devices for use in interventional cardiology, electrophysiology, endoscopy, urology, and neuromodulation.
1. InterDigital, Inc. (NASDAQ:IDCC)
Stock Upside Potential: 71.44%
Number of Hedge Fund Holders: 35
Two Sigma Advisors’ Stake: $73,517,974
InterDigital, Inc. (NASDAQ:IDCC) is one of the best stocks to invest in according to Two Sigma Advisors with huge upside potential. On June 16, InterDigital, Inc. (NASDAQ:IDCC) announced that the Mannheim Local Division of the Unified Patent Court (UPC) had ruled in its favor against The Walt Disney Company. The company said it won an injunction that bars Disney from using one of its patented video encoding technologies across 11 European Union countries simultaneously.
The patent in question covers specific High Efficiency Video Coding, or HEVC, compression techniques. HEVC is a standard used broadly in video streaming to preserve visual quality at lower data rates. According to InterDigital the court found that Disney infringed this patent in its streaming services, including Disney+, and upheld the patent’s validity. At the same time, the court rejected Disney’s FRAND defense, which argued the patent should be licensed on fair, reasonable, and non-discriminatory terms, InterDigital stated.
Court documents show that enforcement of the injunction is subject to InterDigital posting an €8 million security bond. This is despite Disney having sought a much higher security requirement of around €500 million.
Meanwhile, on June 11, William Blair analyst Arjun Bhatia weighed in on InterDigital’s newly announced patent license agreement with Amazon, and estimated that the deal could generate between $40 million and $80 million in recurring annual revenue for the company. This is on top of potential catch-up payments for past usage, Bhatia noted.
InterDigital, Inc. (NASDAQ:IDCC) is a wireless technology research and development company. It designs and develops advanced wireless and video technologies, including standards-essential patents for cellular communications and video compression.
While we acknowledge the potential of IDCC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IDCC and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks and 10 Best Stocks to Buy Now for Good Returns.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
